The aim of our study was to analyze polymorphonuclear neutrophil (PMN) functions in elderly individuals compared with those in healthy young participants, directly in whole blood to avoid issues with data interpretation related to cell isolation procedures. Despite the presence of increased circulating levels of proinflammatory cytokines, resting PMNs from the elderly individuals were not activated as shown by normal CD62L and CD11b expression at the PMN surface and normal constitutive reactive oxygen species (ROS) production. However, suboptimal stimulation induced modulations of CD62L and CD11b expression, which positively correlated with the interleukin-6 circulating level, suggesting a possible in vivo preactivation of old PMNs by this cytokine. In addition, PMN phagocytosis of opsonized Escherichia Coli was decreased in elderly individuals. Furthermore, upon preincubation of elderly whole-blood samples with tumor necrosis factor-α or Toll Receptor agonists, we observed a reduced PMN oxidative burst in response to formyl peptides. Elderly participants also exhibited an increased percentage of the immunosuppressive CD16 bright /CD62L dim PMN subpopulation, which was characterized by a lower phagocytic index and a reduced ROS production compared with the CD16 bright /CD62L bright subset. Thus, the reduced phagocytosis and ROS production associated with an expansion of immunosuppressive CD16 bright /CD62L dim PMN subpopulation might be involved in the increased susceptibility to bacterial and fungal infections with old age.
mechanisms, such as the release of proteolytic enzymes and antimicrobial peptides and the rapid production of reactive oxygen species (ROS) in oxidative burst. After killing of microbes, PMNs die spontaneously, mainly by apoptosis (6) . PMNs are exceptionally sensitive to external stimuli such as proinflammatory cytokines, of which the increased circulating levels have been described as a characteristic of the inflammaging process. In particular, the priming effect of various proinflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-8, and granulocyte-macrophage colony-stimulating factor (GM-CSF), is critical for triggering the polymorphonuclear neutrophil (PMN) oxidative burst in response to bacterial formyl peptides (7, 8) . In addition, PMN activation by circulating microbial products as well as proinflammatory cytokines promotes their survival and is a critical mechanism in their effectiveness against pathogens (9). Finally, IL-17 is a critical mediator in PMN recruitment, migration, and activation (10) .
Over the past few years, it has been demonstrated that PMN chemotaxis (11) , phagocytosis (12, 13) , extracellular trap formation (14, 15) , and rescue from apoptosis induced by proinflammatory mediators (16) (17) (18) (19) are altered with aging. However, there has been a number of controversies related to some functions of old PMNs, especially ROS production; in fact, some authors reported a decreased ROS production with aging (17, 20, 21) , whereas others demonstrated normal (22) or increased (12, 23, 24) PMN oxidative burst in the elderly individuals. Importantly, an issue raised by many of these studies is the analysis of PMNs isolated from their blood environment through various procedures that may differently modulate cell responses (25, 26) . In addition, the modulation through aging of the immunosuppressive PMN subset CD16 bright /CD62L dim , which has been recently reported during severe injury (27, 28) , has never been investigated.
The aim of the present study was to re-examine, in the elderly individuals, PMN status such as the immunosuppressive CD16 bright / CD62L dim subpopulation and PMN functions including adhesion molecule expression, phagocytosis, ROS production, and survival. This study was performed in whole-blood conditions in order to minimize activation due to isolation procedures. This presents the advantage of taking into account the proinflammatory cytokine environment.
Materials and Methods

Study Design and Patients
This cross-sectional study was performed in a cohort of 20 elderly individuals, aged 70-91 years (mean age = 83 years; n = 8 men, n = 12 women), from the Geriatrics Department of the Pitié Salpêtrière Hospital (Paris, France). Elderly individuals with malignancies, acute diseases, or advanced stages of severe chronic diseases, such as chronic inflammatory disease, atherosclerotic disease, congestive heart failure, poorly controlled diabetes mellitus, renal or hepatic disease, or chronic obstructive pulmonary disease, as well as individuals under immunosuppressive therapy were excluded from the study. For comparison, peripheral blood from 20 young healthy control participants (7 men and 13 women), aged 23-35 years (mean age = 31 years), was collected at the Etablissement Français du Sang (EFS, Pitié salpêtrière Hospital, Paris, France) after ethical approval for the use of such material by the institutional review committees of INSERM and EFS (convention 12/EFS/079). The study was approved by the local institutional ethics committee (Comité de Protection des Personnes of the Pitié Salpêtrière Hospital). After written informed consent had been obtained from the patients and the controls, whole blood was sampled, kept on ice, and transported immediately to the laboratory. From fresh ethylenediaminetetraacetic acid (EDTA) blood, the determination of absolute neutrophil count was performed using the Sysmex XE-500 Hematology Analyzer; absolute T-cell counts were determined using CYTOSTAT tetraCHROME kits on a FC500 cytometer (Beckman Coulter, Pasadena, CA) and analyzed with FlowCount Single Platform Method (Beckman Coulter).
Immunophenotyping of T Cells
The expression of cell surface molecules in the T-cell subpopulations was assessed by 10-color flow cytometry (Gallios flow cytometer, Beckman Coulter). The following fluorochrome-conjugated monoclonal anti human antibodies were used: CD45RA-FITC (clone 2H4), CD27-PE (clone 1A4CD27), CD28-ECD (clone CD28.2), CD38-PC5.5 (clone T16), CCR7-PC7 (clone 3D12), CD8-AF700 (clone B9.11), CD3-AF750 (clone UCHT1), CD57-Pacific Blue (clone NC1), and CD4-Krome Orange (clone 13B8.2). All antibodies were purchased from Beckman Coulter except for CCR7, which was obtained from BD Biosciences (San Jose, CA). Samples of 100 µL of fresh whole blood collected in EDTA tubes were labeled for 30 minutes at 4°C with a cocktail of antibodies. The blood was then lysed with BD FACS lysing, and cells were then resuspended with Cell Fix 1X (BD Biosciences) (29) .
Determination of Surface Molecule Expression on Resting and Stimulated PMNs
Heparin whole-blood samples (500 µL) were either kept on ice or incubated with phosphate-buffered saline (PBS), TNF-α (5 ng/mL) or the following toll-like receptor (TLR) agonists: Pam 3 CSK 4 (TLR1/2 agonist, 1 µg/mL, Invivogen, San Diego, CA), lipopolysaccharide (LPS) from Escherichia Coli serotype R515 (TLR4 agonist, 10 ng/mL, Alexis Biochemicals, San Diego, CA) or CL097 (TLR7/8 agonist, 5 µg/mL, Invivogen) for 45 minutes at 37°C. Samples were stained with PE-antihuman CD11b (clone 2LPM19c, Dakopatts, Glostrup, Denmark) and APC-anti-human CD62L (clone DREG-56, BD Biosciences) as previously reported (29) . In order to investigate the immunosuppressive CD16 bright /CD62L dim PMN subset, samples kept on ice were incubated for 30 minutes with FITC-anti-human CD16 (clone 1D3, Beckman Coulter, Brea, CA), PE-anti-human CD11c (clone 3.9, Sony Biotech, San Jose, CA), PE-Cy7-anti-human CD11b (clone Bear 1, Beckman Coulter), and APC-anti-human CD62L (BD Biosciences) antibodies. The blood was then lysed with BD FACS lysing, and cells were then resuspended with Cell Fix 1X (BD Biosciences).
Measurement of Phagocytosis
The percentage of PMN phagocytosing opsonized E. coli as well as the mean fluorescence intensity (MFI) was measured in whole blood by using the Phagotest Kit (Glycotope Biotechnology). Whole-blood samples (100 µL) were incubated with opsonized fluorescein isothiocyanate (FITC)-conjugated E. coli bacteria (2 × 10 7 per 20 µL) for 10 minutes in a water bath at 37°C, the phagocytosis was then stopped in ice and erythrocytes are lysed before analysis by flow cytometry (30) . In some experiments, samples were stained with PE-Cy7-antihuman CD16 (clone 3G8, BD Biosciences) and APC-anti-human CD62L before erythrocytes lysis.
Measurement of the Oxidative Burst of PMNs
Superoxide anion (O 2 -°) production by PMNs was measured using a flow cytometry-based assay derived from the hydroethidine (HE) oxidation technique, as previously described (29) . Heparin wholeblood samples (500 µL) were loaded for 15 minutes with 1,500 ng/ mL HE (Fluka, Buchs, Switzerland) at 37°C and then incubated for 45 minutes with PBS or various stimuli, as described earlier.
Samples were then treated with PBS or 10 −6 M formyl-methionineleucine-phenylalanine (fMLP; Sigma Chemical, St. Louis, MO) for 5 minutes. In some experiments, samples were stained with FITC-antihuman CD16 and APC-anti-human CD62L before erythrocyte lysis.
Measurement of PMN Apoptosis/Necrosis
PMN cell death in whole blood was quantified with annexin V and the impermeant nuclear dye 7-amino-actinomycin D (7-AAD). Whole-blood samples (500 µL) were incubated in 24-well tissue culture plates, for 20 hours, at 37°C with PBS or various stimuli as described earlier. Samples were incubated with APC-anti-CD15 antibodies (clone HI98, BD Biosciences), FITC-annexin V, and 7-AAD (BD Biosciences) as previously described (29) and analyzed by flow cytometry.
Cytokine Assays
Peripheral blood mononuclear cells (PBMCs) were isolated from heparin coagulated peripheral blood (4 mL) by density gradient centrifugation using LymphoPrep (PAA Laboratories, Pasching, Austria). 500,000 PBMCs were then cultured overnight in RPMI 1640 supplemented with 10% FCS, 1% glutamine, 1% pyruvate, 1% antibiotics (Invitrogen GIBCO), and 5 µg/mL of Brefeldin A (BFA, Sigma-Aldrich). For stimulated conditions, staphylococcal enterotoxin B (SEB, 2 µg/ mL, Sigma-Aldrich) was added 30 minutes before BFA. PBMCs were first stained with anti-human CD14-ECD, CD8-AF700, CD3-AF750, and CD4-Krome Orange antibodies (Beckman Coulter), and eFluor 450 Fixable Viability Dye (eBioscience, San Diego, CA). For intracellular analyses, cells were fixed and permeabilized for 45 minutes at 4°C with the Cytofix/Cytoperm kit (BD Biosciences) and incubated with anti-human IL-17A-eFluor 660 (clone eBio64DEC17) and antihuman IL-22-PerCP eFluor 710 (clone 22URTI) antibodies (eBioscience) for 30 minutes at 4°C (29) . Cells were then washed and fixed with BD Cell Fix 1X. Soluble cytokines (IL-6, TNF-α, IL-β) and chemokines (IL-8, IP-10, GROαeotaxin) were also detected from plasma using Luminex assays (Luminex Performance Assays, R&D systems (Abingdon, UK); EDTA whole-blood samples were centrifuged for 15 minutes at 1,000g within 30 minutes of collection. Assays were performed on crystored samples and diluted according to manufacturer's instructions (R&D systems).
Flow Cytometry Analysis
Cells were acquired with a Gallios flow cytometer and analyzed with Kaluza software. To determine the expression of cell surface molecules in the T-cell subpopulations, at least 50,000 events corresponding to lymphocytes according to their forward-and side-scatter characteristics were counted per sample; results were expressed as the percentage of memory CD3 + CD8 + or CD3 + CD4 + cells that express CD38 or CD57 markers. To determine the expression of surface molecules on PMN, and ROS production by PMNs, forward-and side-scatter characteristics were used to identify the PMN population and to gate out other cells and debris, and 10,000 events were counted per sample. Results were expressed as MFI. To measure PMN phagocytosis, a "live" gate on leukocyte was set during data acquisition allowing excluding of bacteria. 10,000 to 15,000 leukocytes were collected per sample, and the granulocyte cluster 
Statistical Analysis
Data are reported as means ± SEM. The Mann-Whitney U test or two-way ANOVA tests with a Tukey posttest were used to determine whether differences were significant between groups, and the Spearman correlation to examine the associations between T-cell activation, neutrophil activation, and cytokine production. We used the Shapiro-Wilk normality test to ensure the normality of distributions in compared groups when using a parametric test. The significance level was set at p < .05. All analyses were performed with GraphPad Prism 5.
Results
Immune Characteristics of Study Participants
We first addressed the global characteristics of the participants included in our study. Elderly individuals exhibited normal absolute neutrophil count (median: 5,415 [3, 200 Figure 1A ). We also analyzed the expression of activation marker (CD38) on memory CD8
+ and CD4 + T-cell subpopulations, which revealed that elderly individuals had higher percentages of CD38 + memory T cells than did young participants ( Figure 1B ), indicating increased immune activation levels.
The median of CRP levels was 5 ng/mL (5-48), which is standard for this age range and highlights the status of systemic inflammation of the elderly person. In addition, we investigated the cytokine environment in the elderly participants. Serum levels of proinflammatory cytokines (IL-6, TNF-α; Figure 1C ) and chemokines (IL-8, IP-10; ( Figure 1D ) were significantly higher in old individuals compared with those in young individuals; in contrast, levels of various other proinflammatory cytokines were similar (IL-1β, GROαeotaxin) in elderly and young participants ( Figure 1C and D) .
Circulating PMNs From Elderly Individuals Are Not Activated
As proinflammatory cytokines are known to modulate PMN functions, we investigated the levels of activated markers in the PMN population. PMN activation is commonly associated with modulations of surface adhesion molecules, specifically a decreased and an increased expression in l-selectin (CD62L) and in β2 integrins (CD11b/CD18), respectively, through either stimulus-induced shedding (37) or translocation from intracellular granules (38) . Nonetheless, as illustrated in Figure 2A and B, the expression of CD62L and CD11b on resting PMNs (samples maintained at 4°C) did not differ between elderly and young participants.
Because PMNs are reported to trigger microbicidal mechanisms upon activation (39), we measured ROS production in unstimulated whole-blood samples. Of note, unstimulated whole-blood PMNs did not produce ROS at higher rates in elderly compared with young participants ( Figure 2C ). Moreover, as PMNs can undergo activation-induced apoptosis (40,41), we measured the percentage of PMNs undergoing spontaneous apoptosis. Immediately after sampling (T0h), the percentage of circulating apoptotic PMNs from young participants was less than 2%. Although cultured wholeblood PMNs died rapidly, mainly by apoptosis (40%) or by necrosis (1.9%), the percentages of apoptotic ( Figure 2D ) and necrotic (annexin V + /7-AAD + ; Figure 2E ) PMNs did not differ between elderly and young participants. Overall, these data indicate that, despite evidence of systemic inflammation and increased circulating levels of proinflammatory cytokines such as IL-6, TNF-α, and IL-8, circulating PMNs from elderly individuals appear mostly resting.
Adhesion Molecules' Expression and Survival of Stimulated PMNs From Elderly Individuals
We next analyzed the responsiveness of PMNs to various stimuli, for example, TNF-α and TLR agonists. After incubation of wholeblood samples with PBS at 37°C for 45 min, we observed lower expression of CD62L ( Figure 3A ) associated with higher CD11b expression ( Figure 3B ) on PMNs from elderly compared with young participants. These results suggest the hyperreactivity of circulating PMNs from elderly individuals to a suboptimal stimulus. Of note, stimulation with TNF-α as well as TLR agonists induced a normal maximal capacity of PMNs from elderly people to shed l-selectin ( Figure 3A ) and to translocate CD11b ( Figure 3B ), in accordance with the preservation of adhesion functions of PMNs (42) . As the PMN activity is highly regulated by proinflammatory mediators, we looked for potential association between this hyperreactivity and levels of proinflammatory cytokines. The IL-6 circulating level was negatively correlated with CD62L expression and positively correlated with CD11b expression on PBS-treated PMNs ( Figure 3C and D). In addition, in accordance with previous data (43), we demonstrated that treatment of whole-blood samples from young participants with IL-6 decreases CD62L expression and increases CD11b expression in a dose-dependent manner (Supplementary Figure 1) . Thus, our results suggest a possible in vivo preactivation of PMNs by this cytokine in the elderly individuals. Apart from IL-6, no correlation was found between CD62L and CD11b expression and the levels of cytokines (data not shown).
As expected (44), incubation of whole-blood samples from young participants with TLR agonists, compared with PBS as a control, significantly decreased the percentage of apoptotic PMNs from young participants. However, in contrast with previous data reported on isolated PMNs cultured in the presence of GM-CSF (16) (17) (18) (19) , the capacity of TLR1/2, TLR4, or TLR7/8 agonists to increase PMN survival was not altered in elderly individuals ( Figure 3E and F) .
Reduced Phagocytosis and Oxidative Burst Responses of PMNs From Elderly Individuals
Phagocytosis is a crucial part of host defense against invading extracellular micro-organisms. We studied the intrinsic capacity of PMN phagocytosis using opsonized bacteria. As previously reported (12,13), we observed that the phagocytic index was significantly lower in elderly individuals reflecting an intrinsic defect in the capacity of PMN phagocytosis ( Figure 4B) .
We have previously reported that, in whole blood, a single stimulus gives rise to minimal ROS production by PMNs (7, 8) . We therefore studied PMN oxidative burst in response to bacterial formyl peptides (fMLP) after priming with TNF-α or TLR agonists. ROS production by control PMNs (sample preincubated with PBS and stimulated with fMLP) did not differ between elderly and young participants suggesting the absence of priming in vivo by proinflammatory mediators, such as circulating cytokines, through aging. After pretreatment of whole blood with TNF-α or TLR agonists followed by fMLP stimulation, ROS production by PMNs from young and elderly participants was significantly increased compared with sample incubated with PBS alone. Interestingly, ROS production by PMNs from elderly individuals was significantly decreased after priming of whole blood with TNF-α or TLR agonists followed by fMLP stimulation (Figure 4C and D) . A similar impairment was observed after PMA stimulation ( Figure 4E) .
No correlation was found between levels of proinflammatory cytokines and ROS production by PMNs suggesting the absence of an in vivo desensitization process. Because IL-17, which plays a critical role in PMN biology (10), was not detected in the serum of elderly individuals, we completed this analysis by studying intracellular production by PBMCs of this cytokine as well as of IL-22, usually produced at the same time as IL-17 (10) . In the absence of any stimulation, although the percentage of IL-17 + cells in elderly participants did not differ from that observed in young participants ( Figure 5A ), the percentage of cell producing IL-22 was significantly higher in old people ( Figure 5B ). After SEB stimulation, PBMCs from elderly individuals showed a decreased capacity for intracellular production of IL-17 ( Figure 5A ). In addition, we found that the decreased percentage of IL-17 + cells after SEB simulation correlated with the decreased ROS production after priming with TLR4 agonist ( Figure 5C ) as well as with TLR1/2 agonist ( Figure 5D ). Nevertheless, we did not observe any priming effect of IL-17 on oxidative burst of PMNs from young participants in response to fMLP (Supplementary Figure 2) . Altogether, these data suggest that the decrease of intracellular IL-17 production and the reduced PMN oxidative burst observed in our study might be independently associated. Immunosuppressive CD62L   dim   /  CD16 bright PMN Subset in Elderly Individuals
Expansion of the
An immunosuppressive CD16 bright /CD62L dim PMN subset, which inhibits T-cell responses, has been recently reported during injuryinduced systemic inflammation (28) . Thus, we analyzed this immunosuppressive PMN subset through aging, a physiological condition associated with a chronic subclinical systemic inflammatory state. As shown in Figure 6A , the CD16 bright /CD62L bright subset constitutes the large majority of PMNs from the young participants, whereas the CD16 dim / CD62L bright and CD16 bright /CD62L dim subpopulations were barely detectable. Among PMNs from the elderly individuals, the percentage of the CD16 dim /CD62L brigh PMN subset did not exceed 3.5% ( Figure 6A ); in contrast, we observed an expansion of the CD16 bright /CD62L dim immunosuppressive subset reaching 14% ( Figure 6A and B). As previously described (27, 28) , the CD16 bright / CD62L dim immunosuppressive subpopulation showed an increased expression of CD11b and CD11c compared with that of the CD16 bright /CD62L bright PMN subset ( Figure 6C ). We then analyzed phagocytosis and ROS production by PMNs from the elderly individuals; PMNs were stained for CD16 and CD62L to discriminate between the subsets. We observed that CD16 bright /CD62L dim PMNs exhibit a lower phagocytic index as well as a lower oxidative burst than CD16 bright / CD62L bright PMNs ( Figure 6D and E). In addition, we found that the increased percentage of CD16 bright /CD62L dim PMNs correlated with the decreased phagocytosis ( Figure 6F ) and the decreased ROS production after priming with TLR4 agonist ( Figure 6G ).
Discussion
A key phenomenon that occurs with age and frailty is the increase in circulating products related to chronic low-grade inflammation commonly associated with the process of "inflammaging" (45) (46) (47) (48) . In Statistical significance as determined by the nonparametric Mann-Whitney test is indicated. **Significantly different from young participants p < .01, ***p < .001. The twoway ANOVA test was used to determine whether differences were significant between the different conditions (treatment with PBS or the various stimuli) for each group (young and elderly participants). For each parameter, samples stimulated with the different agonists were significantly different from sample incubated with PBS p < .001 (not shown).
accordance with these findings, our results show increased levels of the classical proinflammatory cytokines TNF-α, IL-6, IL-8, and IP-10 in elderly individuals. Despite this proinflammatory environment, our results demonstrate the absence of a basal PMN hyperactivation state in the elderly individuals as shown by normal expression of CD62L and CD11b at the surface of resting PMNs and normal constitutive ROS production. In addition, we observed that the percentages of PMNs undergoing spontaneously apoptosis and necrosis did not differ between elderly and young participants. Control of PMN death by apoptosis and subsequent clearance of the apoptotic cells is paramount for effective resolution of inflammation for it enables safe PMN removal and promotes anti-inflammatory responses. In contrast, PMN death by necrosis induces the release of harmful intracellular contents and thus promotes proinflammatory responses (9) . These results suggest that proinflammatory circulating molecules did not contribute to alterations in blood PMNs. Conversely, the normal apoptosis/necrosis equilibrium, combined with the absence of a basal PMN hyperactivation, suggests that PMNs might not be a key determinant in establishing chronic low-grade inflammation in the elderly individuals. Nevertheless, we observed modulations of CD62L and CD11b expression on PBS-treated PMNs from elderly compared with young participants demonstrating an hyperreactivity of circulating PMNs during aging. This hyperreactivity, which might be related at least in part to increased IL-6 circulating levels, could modulate local and systemic inflammatory-immune responses. In a recent study, increased serum levels of a neutrophil proteinase-specific fibrinogen Figure 4A ; PMNs were stained for CD16 and CD62L to discriminate between the subsets; results are expressed as the PMN phagocytic index for both CD16bright/CD62Ldim and CD16bright/ CD62Lbright PMN subsets. (E) ROS production by PMNs was measured after pretreatment of wholeblood samples with PBS, or TLR1/2 agonist, or TLR4 agonist, or TLR7/8 agonist or TNFα and stimulation with fMLP. PMNs were stained for CD16 and CD62L to discriminate between the subsets; results are expressed in MFI for both CD16bright/CD62Ldim and CD16bright/ CD62Lbright PMN subsets. Correlations between the percentage of the the CD16bright/CD62Ldim PMN subset and (F) the PMN phagocytic index or (G) ROS production by TLR4agonistprimed PMNs. The measurements were performed in the elderly participants (n = 10). Values are means ± SEM. Statistical significance as determined by the nonparametric Mann-Whitney test is indicated. °°Significantly different from the CD16bright/CD62Lbright PMN subset p < .01, °°°p < .001. degradation product, consistent with PMN elastase activity, were reported in older donors (11) . In contrast, another study demonstrated similar elastase activity of unstimulated PMNs from elderly and young participants (49) . Further studies are necessary to investigate the release of potentially harmful proteins contained in specific and gelatinase granules.
The anti-apoptotic effect of TLR ligands requires NF-κB and phosphoinositide-3 kinase (PI3K) activation (44) . The protective effect of GM-CSF against apoptosis results from the activation of Lyn (19) , as well as the activation of the MAPK/ERK (18) and the Jak/STAT (50) pathways, and decreased GM-CSF-induced rescue from apoptosis of elderly PMNs has been related to a failure of GM-CSF to activate these pathways in PMNs. These findings might explain the discrepancies between normal TLR agonists-induced PMN survival in the elderly individuals reported in the present study and previous results concerning the defective effect of GM-CSF on PMN survival (50) .
Our results show a reduced ROS production in response to bacterial formyl peptides by whole-blood PMNs after priming with TNF-α or TLR agonists. Decreased ROS production by primed PMNs is associated with a decreased production of IL-17 by stimulated T cells. Contradictory results have been previously reported on the effect of aging on Th17. Some authors reported an increased percentage of IL-17-producing cells in the population of activated CD4 + T cells (51) , whereas others demonstrated a decreased frequency of Th17 cells in the peripheral blood (52) (53) (54) . IL-17 is widely documented as a critical mediator in PMN recruitment, migration, and activation (10) including a direct effect on PMN oxidative burst (55). Because we did not observe any priming effect of IL-17 on PMN oxidative burst in response to fMLP, we can not affirm that the decreased intracellular IL-17 in PBMCs and the reduced oxidative burst are causally related. It is likely that our results reflect two distinct processes indirectly associated. Nevertheless, the decreased frequency of Th17 cells could contribute to increased risk of infections with extracellular pathogens (56, 57) . In parallel, we detected for the first time a basal IL-22 hyperproduction in healthy elderly participants. IL-22 exerts proinflammatory effects; it is present in systemic and local inflammation and exerts an important role in the antimicrobial defense (58) . Interestingly, increased IL-22 circulating levels have been previously reported in healthy centenarians (59) . It is likely that IL-22 has a protective role against infection, promoting the longevity of centenarians. One could speculate that the activity of IL-22 against infection in healthy centenarians may be more relevant for survival than its potentially negative impact on inflammation. Nevertheless, the mechanisms involved in basal IL-22 hyperproduction in elderly participants and its consequence in terms of protection against infection or establishment of chronic inflammation remain to be elucidated.
Reduced ROS production might be related at least in part to changes in the membrane microdomains named lipid rafts, whose integrity is necessary to the assembly of the NADPH oxidase (17, 60) . In contrast to other cells, the fluidity of the PMN membrane increases with aging, due to alterations in the membrane cholesterol/phospholipid composition (61) . The cholesterol content does not change, but the phospholipid content increases. These changes affect the integrity of lipid rafts that is necessary for the assembly of the NADPH oxidase (17, 60) . In addition, reduced levels of TLR4 in lipid rafts as well as impairment of TLR4 signaling in response to LPS in PMNs from elderly donors have been reported (17) . These results cannot explain why in our study LPS was efficient for CD62L shedding, CD11b translocation, and rescue for apoptosis of PMN with aging. We can only speculate that these functions are mediated through different signaling pathways. Alteration of the human fMLP receptor signaling in PMNs from elderly individuals, associated with a decrease of Erk and p38 tyrosine phosphorylation after fMLP stimulation (62) , might also play a role in the reduced oxidative burst.
Several studies support the hypothesis that PMNs are not a homogenous population (63) . In particular, Pillay and colleagues (28) . This subpopulation is capable of suppressing human T-cell proliferation. These cells were observed in humans during in vivo acute systemic inflammation induced by endotoxin challenge or severe injury. Kamp and colleagues (27) reported that the PMN CD16 bright /CD62L dim PMN subset exhibits decreased adhesion to activated endothelium under flow conditions. We observed an increased percentage of this subpopulation in the elderly compared with that in the young participants. In addition, CD16 bright /CD62L dim PMNs exhibit a decreased ROS production and a decreased phagocytosis compared with the CD16 bright /CD62L bright PMN subpopulation. Altogether these data highlight the expansion of the immunosuppressive mature PMN subpopulation in the elderly individuals, a process that can be explained at least in part by the decreased ROS production and the decreased phagocytosis. Further studies are necessary to investigate the mechanisms involved in the expansion of the immunosuppressive PMN subpopulation in the elderly individuals, especially the contribution of the inflammaging process.
Finally, other immune-related changes occurring during aging could impact PMN functions, including oxidative burst. In particular, aging is associated with a gradual loss of the CD56 bright natural killer cell subset, an impairment that can be responsible of the defective production of cytokines and chemokines by natural killer cells observed in elderly individuals (64) . Of note, PMN activation, including priming of ROS production in response to fMLP, is modulated by interaction with natural killer cells through the production of cytokines (65) . In addition, primed PMNs can also be activated by T cells through IL-2 production (66), but a decrease in IL-2 production by T cells occurs with aging (1). Conversely, it will be interesting to investigate the potential role of expanded immunosuppressive PMNs in participating to the decline of the T-cell competence or immunosenescence with advanced age.
Taken together, the present study of PMNs from the elderly individuals demonstrates on the one hand the absence of a basal PMN hyperactivation state despite a chronic low-grade inflammation state, and on the other hand a reduced phagocytosis and oxidative burst responses of PMNs from the elderly individuals associated with the expansion of the immunosuppressive CD16 bright /CD62L dim subset. These alterations might be involved in the increased susceptibility to bacterial and fungal infections through aging.
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